BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21294597)

  • 21. Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients.
    Lin XB; Li ZW; Yan M; Zhang BK; Liang W; Wang F; Xu P; Xiang DX; Xie XB; Yu SJ; Lan GB; Peng FH
    Br J Clin Pharmacol; 2018 Jul; 84(7):1587-1597. PubMed ID: 29607533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
    Andes D; Marchillo K; Stamstad T; Conklin R
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3165-9. PubMed ID: 14506026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic/pharmacodynamic profile of voriconazole.
    Theuretzbacher U; Ihle F; Derendorf H
    Clin Pharmacokinet; 2006; 45(7):649-63. PubMed ID: 16802848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant Recipients.
    Marquet P; Destère A; Monchaud C; Rérolle JP; Buchler M; Mazouz H; Etienne I; Thierry A; Picard N; Woillard JB; Debord J
    Clin Pharmacokinet; 2021 May; 60(5):611-622. PubMed ID: 33230714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation.
    Sarem S; Li J; Barriere O; Litalien C; Théorêt Y; Lapeyraque AL; Nekka F
    Theor Biol Med Model; 2014 Sep; 11():39. PubMed ID: 25192585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population Pharmacokinetic Model and Limited Sampling Strategies for Personalized Dosing of Levofloxacin in Tuberculosis Patients.
    van den Elsen SHJ; Sturkenboom MGG; Van't Boveneind-Vrubleuskaya N; Skrahina A; van der Werf TS; Heysell SK; Mpagama S; Migliori GB; Peloquin CA; Touw DJ; Alffenaar JC
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30373800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy.
    Huang W; Zheng Y; Huang H; Cheng Y; Liu M; Chaphekar N; Wu X
    Eur J Clin Pharmacol; 2022 Sep; 78(9):1447-1457. PubMed ID: 35764817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetic study of cyclosporine based on NONMEM in Chinese liver transplant recipients.
    Sun B; Li XY; Gao JW; Rui JZ; Guo YK; Peng ZH; Liu GL
    Ther Drug Monit; 2010 Dec; 32(6):715-22. PubMed ID: 21068646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults.
    Driscoll TA; Yu LC; Frangoul H; Krance RA; Nemecek E; Blumer J; Arrieta A; Graham ML; Bradfield SM; Baruch A; Liu P
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5770-9. PubMed ID: 21968355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults.
    Driscoll TA; Frangoul H; Nemecek ER; Murphey DK; Yu LC; Blumer J; Krance RA; Baruch A; Liu P
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5780-9. PubMed ID: 21911570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated population pharmacokinetic analysis of voriconazole in children, adolescents, and adults.
    Friberg LE; Ravva P; Karlsson MO; Liu P
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3032-42. PubMed ID: 22430956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steady-state plasma pharmacokinetics of oral voriconazole in obese adults.
    Pai MP; Lodise TP
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2601-5. PubMed ID: 21422207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.
    Zhao W; Elie V; Baudouin V; Bensman A; André JL; Brochard K; Broux F; Cailliez M; Loirat C; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2010 Apr; 69(4):358-66. PubMed ID: 20406220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of sirolimus in Chinese adult liver transplant recipients: a retrospective study.
    Zhang Y; Zhang X; Zou Y; Sun Y; Li X
    Xenobiotica; 2021 Dec; 51(12):1408-1415. PubMed ID: 34983304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state pharmacokinetics and metabolism of voriconazole in patients.
    Geist MJ; Egerer G; Burhenne J; Riedel KD; Weiss J; Mikus G
    J Antimicrob Chemother; 2013 Nov; 68(11):2592-9. PubMed ID: 23766489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
    Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F
    J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.